ArriVent BioPharma, Inc. (NASDAQ: AVBP), a dynamic player in the biotechnology industry, is capturing investor attention with a compelling potential upside of 73.29%. This clinical-stage biopharmaceutical company, based in Newtown..
Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of innovation in the biotechnology sector, focusing on groundbreaking genome editing treatments. As a clinical-stage company, Intellia’s ambitious pipeline aims to..
For investors seeking opportunities in the biotechnology sector, Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) presents a compelling case with its significant upside potential and promising pipeline. With a current market..
Trevi Therapeutics, Inc. (NASDAQ: TRVI) is drawing significant attention in the biotechnology sector, primarily due to a compelling potential upside of 87.03% based on current analyst ratings. Specializing in the..
CorMedix Inc. (NASDAQ: CRMD) is capturing investor attention with its substantial growth trajectory and impressive potential upside. As a biopharmaceutical company operating in the biotechnology sector, CorMedix is making significant..
Avadel Pharmaceuticals plc (NASDAQ: AVDL), a prominent player in the healthcare sector, operates within the specialized niche of drug manufacturing, focusing on both specialty and generic pharmaceuticals. Headquartered in Dublin,..
SI-BONE, Inc. (NASDAQ: SIBN), a pioneering force in the medical devices sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. Based in Santa Clara, California, SI-BONE..
Gyre Therapeutics, Inc. (GYRE), a dynamic player in the biotechnology sector, is drawing attention from investors with its promising pipeline of anti-inflammatory and anti-fibrotic therapies. Headquartered in San Diego, California,..
